Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5351 of 6351
-
Glowing dye reveals hidden clues in rheumatoid arthritis
Knowledge-focused Recruiting nowLymphatic transport was previously examined by these investigators using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities. They established reliable and reproducible methodologies in RA patients. The purpose of this phase 2 pilot is to study…
Phase 1 • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Mayo clinic launches gut bacteria study for rare plasma cell disorders
Knowledge-focused Recruiting nowA Study to Evaluate Gut Microbiome with POEMS Syndrome and Other Plasma Cell Disorders
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Could vitamin d boost immunity in black prostate cancer patients?
Knowledge-focused Recruiting nowThis early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the body (localized) or has spread to other places in the body (metastatic) and how vitamin D insufficie…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Brain scans reveal new clues to Depression's inner workings
Knowledge-focused Recruiting nowThis study looks at the role of the Nociceptin/Orphanin FQ receptor system in the brain of individuals with current or past major depressive disorder (MDD). It also examines how individuals with a history of depression make certain decisions and which brain regions are involved i…
Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Pfizer offers lifeline: ongoing crizotinib access for cancer patients
Disease control OngoingThe purpose of this continuation study is to provide continued access to crizotinib treatment for eligible participants from a current Pfizer sponsored crizotinib clinical study that is planned to close.
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
90,000-Person kidney study aims to unlock disease secrets
Knowledge-focused Recruiting nowChronic kidney disease (CKD) refers to a variety of different diseases characterized by impairment of kidney structure and/or renal function. The prevalence of CKD in China is as high as 10.8%. With a population of more than 150 million, China has the largest number of CKD patien…
Sponsor: Guangdong Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Heat therapy for lung cancer: early trial ends early
Disease control Stopped earlyAdult patients with non-small cell lung cancer (NSCLC) or oligometastatic lung tumors will all receive microwave ablation (MWA) performed percutaneously by doctors who are experienced in lung tumor ablation. 120 patients will participate across 8 clinical study sites all in China…
Sponsor: Ethicon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Protein supplement shows promise for preventing muscle loss in seniors
Disease control CompletedThis study evaluates the effects of a 12-week leucine-enriched protein supplementation in adults aged 60 years and more. Participants will undergo assessments of muscle mass and function, as well as metabolic profiles in blood, urine, and feces before and after the intervention.
Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Early dialysis after heart surgery: study halted, but clues remain
Disease control Stopped earlyAcute kidney injury (AKI) is one of the major complications after cardiac surgery that may affects 20% to 40% of patients according to the definitions. Also, AKI after cardiac surgery is associated with high morbidity and mortality, with eight-fold increase in the odds ratio of d…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
15-Second breath test may guide fluid therapy in sick infants
Knowledge-focused CompletedTo date, the end-expiratory occlusion test in infants or children has never been evaluated as a marker of preload dependence. It therefore appears clinically relevant to evaluate this new indicator to predict fluid responsiveness in all infants hospitalized in pediatric and neona…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Liver cancer combo trial halted early – only 18 patients enrolled
Disease control Stopped earlyThe purpose of this study is to evaluate the safety and efficacy of the combination therapy with HAIC-TACE and donafenib compared to TACE plus donafenib in patients with BCLC B stage unresectable hepatocellular carcinoma (HCC) out of up-to-seven criteria.
Phase 2/3 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New antibody drug tested in patients with Hard-to-Treat cancers
Disease control Completedthe main purpose: * Evaluate the safety and resistance of BAT6026 injection as a single agent in the treatment of patients with locally advanced or metastatic solid tumors Acceptability * Explore maximum tolerated dose (MTD) or maximum administered dose (MAD) and be phase II or …
Phase 1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can an iPad avatar help you quit smoking?
Disease control CompletedThe investigators have developed a hybrid computer- and person-delivered intervention, called "C-Raven" for smoking cessation that is tailored to people with tobacco use in Baltimore City. The computer delivered component consists of two \~20 minute sessions on an iPad guided by …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Minnesota program aims to keep injured workers employed
Knowledge-focused CompletedMN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored joi…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study tracks brain function after radiation for head and neck cancer
Knowledge-focused Recruiting nowThe researchers are doing this study to collect more information about if, and how, neurocognitive function may be affected in people being treated with radiation therapy for head and neck cancer. Part of this study is to see if patients diagnosed with head and neck cancer who ar…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Scientists collect heart biopsies to decode heart disease mysteries
Knowledge-focused Recruiting nowUse samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by a variety of cardiac diseases and therapeutic interventions.
Sponsor: Kenneth S. Campbell • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
COVID drug trial for kids halted early
Disease control Stopped earlyThe purpose for this study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Scientists dive deep into immune system to unlock HPV vaccine secrets
Knowledge-focused CompletedThis is a single center, longitudinal cohort study in which subjects will receive 9-valent HPV vaccine according to package insert (i.e., one dose of 9-valent HPV vaccine on day (D) 0 followed by a second dose 2 months later and a third dose 6 months later). Immune responses in …
Phase 4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Experimental drug iptacopan tested for rare blood disorders
Disease control Stopped earlyThe main purpose of this study was to evaluate the efficacy and safety of iptacopan in participants with autoimmune benign hematological disorders such as primary immune thrombocytopenia and primary cold agglutinin disease.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
CF gene carriers may face hidden organ risks
Knowledge-focused Recruiting nowThe overarching hypothesis is that CF carriers are at increased risk for developing most of the extrapulmonary conditions associated with CF compared to the general population. Specifically, it is hypothesized that this pilot data will detect subclinical evidence of pancreatic an…
Sponsor: Philip Polgreen • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC